EyePoint Pharmaceuticals Inc.
EYPT | NASDAQ
$4.19
+$0.17 (+4.23%)
Sep 22, 2026, 12:20 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 507K | 696K | 620K | 966K | 5.33M | 24.45M | 11.59M | 10.52M | 9.48M | 11.68M | 14.03M | 15.2M | 9.11M | 7.68M | 10.53M | 10.01M | 11.57M | 9.29M | 11.54M | 9.06M | 9.01M | 7.32M |
Cost of Revenue | n/a | 528K | 375K | 721K | 165K | 805K | 816K | 736K | 1.4M | 759K | 998K | 1.2M | 1.79M | 640K | 3.41M | 1.41M | 1.73M | 1.78M | 3.03M | 1.83M | 1.93M | 1.39M |
Gross Profit | 507K | 168K | 245K | 245K | 5.17M | 23.65M | 10.77M | 9.79M | 8.08M | 10.93M | 13.03M | 14M | 7.31M | 7.04M | 7.12M | 8.61M | 9.83M | 7.52M | 8.51M | 7.23M | 7.08M | 5.93M |
Operating Income | -97.38M | -87.23M | -70.35M | -62.03M | -62.23M | -48.84M | -45.24M | -32.75M | -34.55M | -33.32M | -16.35M | -14.4M | -22.76M | -21.55M | -43.74M | -18.4M | -19.22M | -18.28M | -18.05M | -15.31M | -10.98M | -10.94M |
Interest Income | 2.91M | 2.34M | 2.92M | 2.29M | 2.89M | 3.64M | 3.94M | 3.39M | 3.72M | 4.04M | 2.34M | 1.79M | 1.62M | 1.2M | 1.06M | 640K | 362K | 61K | 6K | 6K | 280K | 1K |
Pretax Income | -94.47M | -84.88M | -67.42M | -59.73M | -59.33M | -45.2M | -41.31M | -29.36M | -30.83M | -29.28M | -14.02M | -12.61M | -22.92M | -21.16M | -43.45M | -18.42M | -19.41M | -20.98M | -19.43M | -16.7M | -10.01M | -12.28M |
Net Income | -94.47M | -84.83M | -67.61M | -59.73M | -59.43M | -45.2M | -41.4M | -29.36M | -30.83M | -29.28M | -14.1M | -12.61M | -22.92M | -21.16M | -43.45M | -18.42M | -19.41M | -20.98M | -19.43M | -16.7M | -10.01M | -12.28M |
Selling & General & Admin | 14.27M | 15.25M | 11.38M | 14.52M | 11.9M | 13.91M | 12.64M | 12.99M | 12.8M | 14.11M | 11.43M | 11.04M | 14.34M | 14.98M | 14.41M | 15.23M | 15.44M | 15.24M | 17.03M | 13.43M | 11.84M | 10.77M |
Research & Development | 83.61M | 72.15M | 59.21M | 47.75M | 55.5M | 58.57M | 43.37M | 29.54M | 29.82M | 30.14M | 17.95M | 17.36M | 15.73M | 13.62M | 15.54M | 11.16M | 12.99M | 9.95M | 8.92M | 8.5M | 5.61M | 5.48M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.9M | 615K | 615K | 615K | 615K | 615K | 615K | 615K |
Operating Expenses | 97.89M | 87.39M | 70.59M | 62.27M | 67.4M | 72.49M | 56.01M | 42.54M | 42.62M | 44.25M | 29.38M | 28.4M | 30.07M | 28.6M | 50.86M | 27.01M | 29.05M | 25.8M | 26.56M | 22.55M | 18.06M | 16.87M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 14K | n/a | n/a | n/a | n/a | n/a | 435K | 812K | 781K | 662K | 552K | 1.19M | 1.39M | 1.39M | 1.38M | 1.35M |
Selling & Marketing Expenses | 31K | 3K | -6K | 26K | 35K | 35K | 51K | 24K | 50K | 6K | 185K | 479K | 5.29M | 5.74M | 5.92M | 6.02M | 6.88M | 6.69M | 7.81M | 7.37M | 6.66M | 5.66M |
Cost & Expenses | 97.89M | 87.92M | 70.97M | 62.99M | 67.56M | 73.29M | 56.83M | 43.27M | 44.02M | 45.01M | 30.38M | 29.6M | 31.87M | 29.24M | 54.27M | 28.41M | 30.78M | 27.58M | 29.59M | 24.37M | 19.99M | 18.26M |
Income Tax Expense | n/a | 50K | -186K | n/a | 93K | n/a | 90K | n/a | n/a | n/a | 83K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 86.54M | 86M | 83.03M | 70.17M | 69.93M | 69.77M | 64.56M | 54.45M | 53.21M | 52.91M | 42.17M | 38.34M | 37.58M | 37.49M | 37.35M | 37.34M | 37.32M | 37.25M | 32.7M | 28.77M | 28.6M | 24.74M |
Shares Outstanding (Diluted) | 86.54M | 86M | 83.03M | 70.17M | 69.93M | 69.77M | 64.56M | 54.45M | 53.21M | 52.91M | 42.17M | 38.34M | 37.58M | 37.49M | 37.35M | 37.34M | 37.32M | 37.25M | 32.7M | 28.77M | 28.74M | 24.74M |
EPS (Basic) | -1.09 | -0.99 | -0.81 | -0.85 | -0.85 | -0.65 | -0.64 | -0.54 | -0.58 | -0.55 | -0.33 | -0.33 | -0.61 | -0.58 | -1.72 | -0.49 | -0.52 | -0.60 | -0.59 | -0.58 | -0.35 | -0.50 |
EPS (Diluted) | -1.09 | -0.99 | -0.81 | -0.85 | -0.85 | -0.65 | -0.64 | -0.54 | -0.58 | -0.55 | -0.33 | -0.33 | -0.61 | -0.58 | -1.72 | -0.49 | -0.52 | -0.60 | -0.59 | -0.58 | -0.35 | -0.50 |
EBITDA | -93.14M | -84.25M | -57.86M | -59.16M | -58.8M | -44.7M | -40.83M | -28.95M | -30.46M | -28.98M | -13.9M | -12.5M | -22.35M | -20.25M | -42.34M | -17.05M | -18.15M | -19.09M | -17.35M | -14.69M | -7.95M | -10.25M |
EBIT | -94.47M | -84.88M | -58.56M | -59.73M | -59.33M | -45.2M | -41.3M | -29.36M | -30.83M | -29.28M | -14.02M | -12.61M | -22.49M | -20.35M | -42.67M | -17.76M | -18.85M | -19.78M | -18.04M | -15.31M | -8.63M | -10.93M |
Depreciation & Amortization | 1.33M | 636K | 698K | 576K | 538K | 497K | 467K | 408K | 362K | 303K | 112K | 115K | 132K | 105K | 335K | 711K | 704K | 696K | 698K | 615K | 685K | 687K |
Add to Watchlist
Select watchlists to add or remove EYPT